• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
CHF
Therapeutic Goals
1. Elimination of precipitating cause of symptoms

2. Management of heart failure

3. Increased cardiac output and enhanced tissue and organ profusion

4. Modulation of neurohumoral response
CHF
Compensatory Mechanism
(Increased Sympathetic Activity)
Activation of BETA-adrenergic receptor in the heart
LEADS TO
Increase in heart rate and cardiac output
LEADS TO
Vasoconstriction
LEADS TO
Enhanced venous return and increased cardiac output
CHF
Compensatory Mechanism
(Fluid Retention)
Decreased cardiac output
LEADS TO
Decreased blood flow to kidney
LEADS TO
Increased renin, angiotensin II, and aldosterone
LEADS TO
Increased peripheral resistance and retention of Na+ and water
LEADS TO
Increased blood volume
CHF
Compensatory Mechanism
(Myocardial and Cardiac Remodeling)
Ventricular hypertrophy

Myocardial structural and functional alterations

Change in cardiac size, shape, and composition
CHF
Compensatory Mechanism
(Neurohormonal)
Increase in Angiotensin II
Increase in Aldosterone
Increase in Norepinephrine
Increase in Endothelin
Increase in Vasopressin
CHF Risk Factors
Age
Coronary Artery Disease
Hypertension
Smoking
Alcohol
Thyroid Disease
Rheumatic Heart Disease
Cardiotoxic Drugs
4 Categories of HF
Stage A: Patients at high risk of developing HF due to conditions present that are strongly associated with development of HF
Stage B: Patients with structural heart disease highly associated with development of HF, but who have not had signs or symptoms of HF
Stage C: Patients with current or past symptoms of HF with underlying structural heart disease
Stage D: Patients with progressive structural heart disease and marked symptoms of HF at rest
Diuretic Resistance
Dx: Patient that does not respond to loop diuretics alone

Tx: Furosimide and Metolazone
(Lowers the chances of resistance and is the only time that metolazone is used as a diuretic)